Treatment with ticagrelor alone results in a lower rate of clinically relevant bleeding compared with ticagrelor and aspirin among patients with an acute coronary syndrome who had percutaneous coronary intervention and remained ...
Apr 13, 2024
0
10
Withdrawing aspirin one month after percutaneous coronary intervention (PCI) in high-risk heart patients and keeping them on ticagrelor alone safely improves outcomes and reduces major bleeding by more than half when compared ...
Apr 7, 2024
0
55
The most common chronic liver disease—metabolic dysfunction–associated steatotic liver disease (MASLD)—is characterized by an increased buildup of fat in the liver due to factors such as obesity and type 2 diabetes.
Mar 25, 2024
0
47
Heart disease researchers have identified a group of patients for whom international guidelines on aspirin use for heart health may not apply.
Feb 27, 2024
0
1
Researchers at Kennedy Krieger Institute and Boston Children's Hospital have discovered a new way to decrease early seizure likelihood and improve neurologic outcomes among infants with Sturge-Weber Syndrome (SWS). This collaboration ...
Jan 12, 2024
0
0
Combined clopidogrel-aspirin therapy initiated within 72 hours after stroke onset leads to lower risk for new stroke at 90 days among patients with mild ischemic stroke or high-risk transient ischemic attack (TIA) of presumed ...
Dec 29, 2023
0
1
Aspirin is an inexpensive and readily available medication that could benefit cancer treatments, preventing metastatic cancer spread and reducing vascular complications, finds a new meta-analysis study.
Dec 4, 2023
0
18
A new study led by Professor Laura Magee, has found that among pregnancies with clinical risk factors for pre-eclampsia or fetal growth restriction, measuring serum placental growth factor (PlGF) at the time of the routine ...
Nov 14, 2023
0
0
Should you be taking daily aspirin to prevent a first heart attack or stroke? New Canadian guidelines released over the weekend suggest it's not for everyone.
Oct 30, 2023
0
4
Use of low-dose aspirin (LDA) among pregnant women with inflammatory bowel disease (IBD) is not associated with an increased risk for disease activity, according to a study presented at the annual meeting of the American ...
Oct 27, 2023
0
0
